Home/Filings/4/0001209191-21-059131
4//SEC Filing

Vieser Jaime 4

Accession 0001209191-21-059131

CIK 0001107421other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 6:11 PM ET

Size

8.0 KB

Accession

0001209191-21-059131

Insider Transaction Report

Form 4
Period: 2021-09-29
Vieser Jaime
Director
Transactions
  • Purchase

    Common Stock

    2021-09-29$1.91/sh+100,000$191,000705,321 total
Holdings
  • Common Stock

    (indirect: By Children)
    75,000
  • Common Stock

    (indirect: By Children)
    100,000
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.90 to $1.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001846045

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 6:11 PM ET
Size
8.0 KB